Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019

June 10, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search